10-12 September 2018 //  Lancaster Royal Hotel, London

Provecs Medical


Provecs Medical, Associate Sponsor at Cell & Gene Therapy Europe

Provecs Medical is an innovative immune-oncology company founded in Hamburg, Germany. Provecs develops unique multivalent immunotherapeutics to reprogram the tumour microenvironment. Core technologies: the adenoviral platform ENVIRO and the proof-of-concept platform EXVIRO for lead identification and qualification applying high through-put technologies like transcriptome profiling, bioinformatics, and tissue immune imaging technologies.

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad